Correlation Between Vaxcyte and Agenus
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Agenus Inc, you can compare the effects of market volatilities on Vaxcyte and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Agenus.
Diversification Opportunities for Vaxcyte and Agenus
Poor diversification
The 3 months correlation between Vaxcyte and Agenus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Vaxcyte i.e., Vaxcyte and Agenus go up and down completely randomly.
Pair Corralation between Vaxcyte and Agenus
Given the investment horizon of 90 days Vaxcyte is expected to under-perform the Agenus. But the stock apears to be less risky and, when comparing its historical volatility, Vaxcyte is 1.9 times less risky than Agenus. The stock trades about -0.06 of its potential returns per unit of risk. The Agenus Inc is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 405.00 in Agenus Inc on November 1, 2024 and sell it today you would lose (51.00) from holding Agenus Inc or give up 12.59% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Vaxcyte vs. Agenus Inc
Performance |
Timeline |
Vaxcyte |
Agenus Inc |
Vaxcyte and Agenus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaxcyte and Agenus
The main advantage of trading using opposite Vaxcyte and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Agenus vs. Marker Therapeutics | Agenus vs. Edgewise Therapeutics | Agenus vs. Adaptimmune Therapeutics Plc | Agenus vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |